Thursday, April 3, 2014
Publication and contact
Hexamer-forming mAbs that
activate the complement system
mAbs engineered with
mutations that promote hexamer formation could help treat infections and
cancer by activating the complement system. The complement system is a part
of the innate immune system that helps to eliminate pathogens and tumor
cells. In cell culture, multiple IgGs engineered with an E345R mutation had
greater complement-dependent cytotoxicity than unmodified variants. In
vitro, IgGs with the E345R mutation were better than control IgGs at
forming hexameric structures that activated complement
component 1 q subcomponent (C1q)
after binding to their target antigen. Next steps include selecting
complement activation-enhancing mutations and specific mAb variants to use in
HexaBody platform for generating therapeutic antibodies.
Genmab uses its HexaBody platform to design mAbs that have an improved
ability to eliminate pathogens and tumor cells while retaining their regular
structure and specificity (see Complementing mAbs, page 7).
Published online April 3, 2014
Patent application filed;
available for licensing and partnering
Diebolder, C.A. et al.
Science; published online March 14, 2014;
Contact: Paul W.H.I. Parren, Genmab A/S, Utrecht, the Netherlands
Contact: Piet Gros, Utrecht University, Utrecht, the Netherlands
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]